Multicenter Clinical Trial Evaluating the Immunological Response of Vaccination Against Infection by Human Papillomavirus (HPV) 6, 11, 16, 18 in Girls Receiving Immunosuppressive Therapy.
Latest Information Update: 22 Jul 2024
At a glance
- Drugs V 503 (Primary) ; Corticosteroids; Immunosuppressants
- Indications Cervical cancer; Cervical dysplasia; Genital warts; Human papillomavirus infections; Vulvar dysplasia
- Focus Therapeutic Use
- Acronyms PRIMAVERA
- 16 Jul 2024 Status changed from active, no longer recruiting to completed.
- 30 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 12 Dec 2013 Planned end date changed from 1 Aug 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov.